News

Data show no significant difference in time to first heart failure rehospitalization or death compared to usual care in patients with HFrEF.

Treatment was associated with reductions in IGA scores as well as inflammatory and non-inflammatory lesion counts.

The priorities established by a panel of experts are designed to improve efficacy and equity in kidney research and care.

There was no association found between migraines and Crohn’s disease or ulcerative colitis.

A co-located model of care may be highly beneficial in easing the transition from pediatric to adult care.

The company expects to continue to study the potential inflammatory bowel disease treatment.

Genotype F was the common genotype found at 5.73 per 1000 person-years of follow-up.

The selective topical PDE4 inhibitor demonstrated rapid improvements in IGA and EASI scores and high tolerability in pediatric populations.

Patients with IBD, rheumatoid arthritis, and psoriasis are commonly treated using biologic agents such as infliximab, tofacitinib, and ustekinumab.

Dr. Martin explains the connection between inclusive cardiology technology and patient care and confidence.

In part 2 of an interview with HCPLive, Ty Gluckman, MD discusses both the advantages and disadvantages of technology replacing traditional care.

Marc Bonaca, MD discusses the personalization of treatment in PAD patients, lack of proper research into the condition, and optimizing delivery of care.

Ty Gluckman, MD speaks on the use of medical technology, including wearables and and telemedicine, and the growing importance of mobile health.

Harold Bays, MD discussed the effectiveness of GLP-1 RA in treatment, as well as the development of oral semaglutide.

Dr. Taub speaks on the technology-based advancements in cardiovascular care and socioeconomic status can affect a patient’s diet and access to care.

Peter Toth, MD discusses the combination treatment aspects of lipid management agents, as well as the effect of the COVID-19 pandemic on cardiovascular care.

Dr. Pam Taub speaks on the misconceptions of cardiac rehabilitation and other lifestyle approaches recommended for patients with cardiovascular diseases.

Peter Toth, MD, discusses the movement towards new agents in treatment of lipid management.

Dr. Mazzocchi discusses the limits and benefits of immunotherapies, as well as the importance of genetic testing in determining cancer diagnosis and treatment in patients.

Exenatide extended-release represents the first regulatory approval for a once-weekly glucagon-like peptide-1 receptor agonist (GLP-1 RA) for pediatric patients with type 2 diabetes.

Males and patients with higher disease severity were more likely to attend program sessions.

New guidelines on aortic valve implantation in risk groups with aortic stenosis shifted from risk strata to a focus on patient age and life expectancy.

More research is needed to understand the pathogenesis underlying this association.

The treatment was associated with an increased risk of C difficile colitis.

While investigators did not meet their primary endpoint in the study, results in former smokers within the trial were promising and prompted further research on the subgroup.

The FDA will also not meet the PDUFA date for tofacitinib for the treatment of active ankylosing spondylitis.

CBGT and MBSR were both associated with a significant decrease in negative emotion.

Data show a significant association between wearable tracker use and increased physical activity during a 15-week period.